Brief: Guard Therapeutics To Carry Out New Share Issue Of SEK 120 Million

Disruptive Pharma AB (publ)

11/11/2022 06:49

Nov 11 (Reuters) - Guard Therapeutis AB  GUARD.ST :
    * SAID ON THURSDAY INTENDS TO EXPLORE THE CONDITIONS TO
CARRY OUT
A DIRECTED SHARE ISSUE OF APPROXIMATELY SEK 115 MILLION
    * EXISTING SHAREHOLDERS, WHO TOGETHER HOLD ABOUT 33% OF
SHARES IN
GUARD THERAPEUTICS HAVE UNDERTAKEN TO VOTE FOR APPROVAL OF
TRANCHE 2 AT EGM
    * PROCEEDS TO BE USED TO SECURE COMPLETION OF PHASE 2 STUDY
(AKITA) AND TO FINANCE SELECTED PREPARATORY PHASE 3 ACTIVITIES
INCLUDING CMC DEVELOPMENT
    * DECIDED TO CARRY OUT A DIRECTED SHARE ISSUE OF SEK 120
MILLION,
PARTLY SUBJECT TO SUBSEQUENT APPROVAL BY AN EXTRAORDINARY
GENERAL MEETING

        
 Source text for Eikon:  urn:newsml:reuters.com:*:nMFN3ThHbp
 Further company coverage:  GUARD.ST  
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))